The spinout will develop research on drugs that could one day shorten the lifespan of cancerous cells.
Tech Launch Arizona, the tech transfer office of University of Arizona (UA), has transferred a licence for a drug candidate that destroys cancer cells to its US-based spinout Reglagene.
Reglagene will seek to tackle gene processes by which DNA sequences begin to deteriorate during diseases such as cancer.
By developing a faster route to deactivating the DNA structures responsible, Reglagene hopes it might pave the way for drugs to shorten the lifespan of cancerous cells.
Arizona Centre for Innovation, the…